Bastian Patrick J, Ellinger Jörg, Heukamp Lukas C, Kahl Philip, Müller Stefan C, von Rücker Alexander
Klinik und Poliklinik für Urologie, Universitätsklinikum Bonn, Rheinische Friedrich-Wilhelms Universität Bonn, Germany.
Eur Urol. 2007 Mar;51(3):665-74; discussion 674. doi: 10.1016/j.eururo.2006.08.008. Epub 2006 Aug 23.
To evaluate CpG island hypermethylation in a set of candidate genes in prostate cancer (pCA) and its relationship to clinicopathologic parameters and a nomogram predicting prostate-specific antigen (PSA) recurrence after radical prostatectomy.
Tissues of 78 prostate carcinomas, 32 benign prostate hyperplasias (BPHs), and prostate cell lines (LNCaP, DU145, PC3, BPH-1) were examined with MethyLight polymerase chain reaction at 13 gene loci (APC, CDC6, CTNNB1, E-Cadherin, EDNRB, FGFR2, GSTP1, NAB2, PKCmu, PTGS2, RAR-beta, RASL11A, WWOX).
APC, RAR-beta, PTGS2, GSTP1, EDNRB, and CTNNB1 (83%, 71%, 65%, 33%, 14%, 9%, respectively) were methylated in pCA but rarely or not methylated in BPH. NAB2 and CDC6 were hypermethylated frequently in pCA (92%, 67%, respectively) and in BPH (91%, 59%, respectively). FGFR2, WWOX, E-Cadherin, PKCmu, and RASLL1A did not display noteworthy methylation in pCA (0-1%) or in BPH. CpG island hypermethylation at APC, retinoic acid receptor beta (RAR-beta), and PTGS2 discriminated with a sensitivity of 65-83% and a specificity of 97-100% between BPH and pCA. The combination of various genes increased the diagnostic expressiveness. PTGS2 hypermethylation correlated with seminal vesicle infiltration (p=0.047), capsular penetration (p=0.004), and pT stage (p=0.014). RAR-beta methylation was accompanied by a higher cumulative Gleason score (p=0.042). The probability of PSA-free-survival calculated with a Kattan nomogram correlated inversely with CpG island hypermethylation at EDNRB, RAR-beta, and PTGS2. All prostate cancer cell lines displayed a varying degree of demethylation after 5-aza-2'deoxycytidine treatment.
CpG island hypermethylation at various gene loci is frequent in prostate cancer and can distinguish between neoplastic and noncancerous tissue. Furthermore, hypermethylation at PTGS2, RAR-beta, and EDNRB inversely correlated with PSA-free-survival according to a Kattan nomogram and has potential prognostic value.
评估一组前列腺癌(pCA)候选基因中的CpG岛高甲基化及其与临床病理参数的关系,以及与预测前列腺癌根治术后前列腺特异性抗原(PSA)复发的列线图之间的关系。
采用甲基化荧光定量聚合酶链反应检测78例前列腺癌组织、32例良性前列腺增生(BPH)组织及前列腺癌细胞系(LNCaP、DU145、PC3、BPH-1)中13个基因位点(APC、CDC6、CTNNB1、E-钙黏蛋白、EDNRB、FGFR2、GSTP1、NAB2、PKCμ、PTGS2、视黄酸受体β(RAR-β)、RASL11A、WWOX)的甲基化情况。
APC、RAR-β、PTGS2、GSTP1、EDNRB和CTNNB1在pCA中发生甲基化(分别为83%、71%、65%、33%、14%、9%),而在BPH中很少或未发生甲基化。NAB2和CDC6在pCA(分别为92%、67%)和BPH(分别为91%、59%)中频繁发生高甲基化。FGFR2、WWOX、E-钙黏蛋白、PKCμ和RASL1A在pCA(0-1%)或BPH中未显示出明显的甲基化。APC、视黄酸受体β(RAR-β)和PTGS2的CpG岛高甲基化在区分BPH和pCA时,灵敏度为65-83%,特异性为97-100%。多种基因的联合可提高诊断效能。PTGS2高甲基化与精囊浸润(p=0.047)、包膜侵犯(p=0.004)及pT分期(p=0.014)相关。RAR-β甲基化与更高的累积Gleason评分相关(p=0.042)。根据Kattan列线图计算的无PSA生存概率与EDNRB、RAR-β和PTGS2的CpG岛高甲基化呈负相关。所有前列腺癌细胞系在5-氮杂-2'-脱氧胞苷处理后均表现出不同程度的去甲基化。
多种基因位点的CpG岛高甲基化在前列腺癌中很常见,可区分肿瘤组织和非肿瘤组织。此外,根据Kattan列线图,PTGS2、RAR-β和EDNRB的高甲基化与无PSA生存呈负相关,具有潜在的预后价值。